1. Home
  2. TNGX vs MVIS Comparison

TNGX vs MVIS Comparison

Compare TNGX & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • MVIS
  • Stock Information
  • Founded
  • TNGX 2014
  • MVIS 1993
  • Country
  • TNGX United States
  • MVIS United States
  • Employees
  • TNGX N/A
  • MVIS N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • MVIS Industrial Machinery/Components
  • Sector
  • TNGX Health Care
  • MVIS Technology
  • Exchange
  • TNGX Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • TNGX 317.4M
  • MVIS 308.8M
  • IPO Year
  • TNGX N/A
  • MVIS 1996
  • Fundamental
  • Price
  • TNGX $1.76
  • MVIS $1.35
  • Analyst Decision
  • TNGX Strong Buy
  • MVIS Buy
  • Analyst Count
  • TNGX 7
  • MVIS 4
  • Target Price
  • TNGX $12.33
  • MVIS $2.67
  • AVG Volume (30 Days)
  • TNGX 801.9K
  • MVIS 7.5M
  • Earning Date
  • TNGX 05-07-2025
  • MVIS 05-08-2025
  • Dividend Yield
  • TNGX N/A
  • MVIS N/A
  • EPS Growth
  • TNGX N/A
  • MVIS N/A
  • EPS
  • TNGX N/A
  • MVIS N/A
  • Revenue
  • TNGX $42,069,000.00
  • MVIS $8,147,000.00
  • Revenue This Year
  • TNGX N/A
  • MVIS N/A
  • Revenue Next Year
  • TNGX N/A
  • MVIS $330.45
  • P/E Ratio
  • TNGX N/A
  • MVIS N/A
  • Revenue Growth
  • TNGX 15.17
  • MVIS 277.53
  • 52 Week Low
  • TNGX $1.71
  • MVIS $0.80
  • 52 Week High
  • TNGX $12.02
  • MVIS $1.95
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 31.59
  • MVIS 53.56
  • Support Level
  • TNGX $1.80
  • MVIS $1.23
  • Resistance Level
  • TNGX $2.04
  • MVIS $1.48
  • Average True Range (ATR)
  • TNGX 0.21
  • MVIS 0.13
  • MACD
  • TNGX 0.01
  • MVIS 0.02
  • Stochastic Oscillator
  • TNGX 3.94
  • MVIS 79.59

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: